Restrictive cardiomyopathy manifests as congestive ... Iron deposition can be detected by biopsy, as well. Treatment is aimed at the primary etiology, if possible; however, no specific therapy ...
The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...
New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Amyloid cardiomyopathy (cardiac amyloidosis) is a form of restrictive cardiomyopathy that ... form of TTR cardiac amyloidosis, as both treatment decisions and the need (or lack thereof) for ...
Heart failure with preserved LV ejection fraction (eg, restrictive cardiomyopathy ... Toxicity risk increased by potassium-depleting drugs (eg, diuretics, amphotericin B, corticosteroids).
Peripartum cardiomyopathy (PPCM), a systolic dysfunction ... because delays in starting therapy can lead to adverse events. Treatment for PPCM is about the same as for heart failure, although ...
Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...
The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback